CMC

TORONTO, Canada; HAIFA, Israel; and POMPANO BEACH, Florida, April 7, 2026 NurExone Biologic Inc. announced that its U.S. subsidiary...

Child-Friendly MB-204 Formulation Targets Neuro Disorders – February 18, 2026 | Calgary, Alberta Marvel Biosciences Corp. has secured advisory...

San Francisco, CA – December 4, 2025 — Twist Bioscience today announced the launch of a new line of...

Dateline Introduction Burlington, Massachusetts — November 18, 2025 — Lifordi Immunotherapeutics has announced a strategic investment from Sanofi Ventures,...